With one blood sampling, AminoIndex® instantly detects current and future disease risks from amino acid balance in blood.
AICS® (AminoIndex® Cancer Screening)
This is a test designed for the assessment of cancer risks by using AminoIndex®.
AICS for males (5 types)：gastric cancer, lung cancer, colorectal cancer, pancreatic cancer, prostate cancer
AICS for females (6 types)：gastric cancer, lung cancer, colorectal cancer, pancreatic cancer,
breast cancer, uterine cancer (cervical cancer, endometrial cancer)/ovarian cancer
AILS ® (AminoIndex® LifeStyle diseases)
This assesses the risk of diabetes within 4 years and stroke/myocardial infarction within 10 years as well as the current reduction of
essential/semiessential amino acids in blood to report a type ranging from I to IV as a result of these tests. Based on this type, information on lifestyle improvements is provided.
Orders of AILS® only cannot be accepted.
AminoIndex®
AminoIndex® is an analytical service that utilizes technology to find out about the health conditions
and potential of diseases based on blood concentrations of various amino acids.
AminoIndex® analysis is performed by Ajinomoto Co., Inc.
Points to consider concerning analysis
AIRS® is a test that has been developed for
the Japanese individuals (excluding pregnant women) of the age groups listed below.
Those who are not belonged to any of these groups are excluded from assessment.
test name
Assessment targets
Age indicated
Male
AICS (5 types)
stomach cancer, lung cancer, colon cancer, pancreatic cancer
25 years - 90 years
prostate cancer
40 years - 90 years
AILS (risk of cerebral/cardiac diseases )
risk of stroke/myocardial infarction within 10 years
30 years - 74 years
AILS (risk of diabetes mellitus)
risk of diabetes mellitus within 4 years
20 years - 80 years
AILS (amino acid level)
reduction of essential/semiessential amino acids in blood
Female
AICS (6 types)
stomach cancer, lung cancer, colon cancer, pancreatic cancer, breast cancer
25 years - 90 years
cervical cancer, ovarian cancer
40 years - 90 years
AILS (risk of cerebral/cardiac diseases )
risk of stroke/myocardial infarction within 10 years
30 years - 74 years
AILS (risk of diabetes mellitus)
risk of diabetes mellitus within 4 years
20 years - 80 years
AILS (amino acid level)
reduction of essential and semiessential amino acids in blood
*AILS (risk of cerebral/cardiac diseases) values of patients with stroke/myocardial infarction (including patients on treatment), AILS (risk of diabetes mellitus) values of patients with diabetes mellitus (including patients on treatment) , as well as the types based on their test results are not subject to assessment.
The test should not be performed on the following individuals due to possible impact on their AICS values: those who are pregnant; are breast-feeding; have cancer (including those on therapy); have inborn error of metabolism; or are undergoing dialysis.
Blood sample should be collected in the morning, from a subject who has refrained from consuming anything other than water (e.g., meals, dietary supplements) for the previous 8 hours, as well as from exercising in the morning on the day of sampling.
Impact of drugs on the test is not clear.
Avoid putting in another request at the same time.
Materials other than plasma (EDTA-2Na) may not be accepted for testing.
Please specify the subject's sex and age when putting in a request.
About handling of samples
Collect approximately 5 mL of blood in an EDTA-2Na tube.
Immediately after collecting, gently mix the blood by inverting the tube 2 to 3 times (do not use a roller for mixing).
Immediately after mixing (within 1 minute after mixing), cool the tube by immersing in ice water
(so that the tube is immersed in an ice bath up to the level of the surface of blood) (≥15 minutes, until ready for centrifuge).
Within 8 hours of blood sampling, centrifuge the sample under refrigerated conditions
(4℃, 3000 rpm, 15 min) or under normal conditions (3000 rpm, 15 min, no temperature rise of the rotor).
Immediately after the centrifugation, collect the supernatant plasma from
the center of it without touching the interface with the blood, and dispense it.
Within 4 hours of dispensing, freeze the plasma samples for storage.
